| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/06/2008 | EP1884516A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 02/06/2008 | EP1884237A1 Protective agent for neurocyte comprising amidino derivative as active ingredient |
| 02/06/2008 | EP1883451A2 Substituted indole compounds having nos inhibitory activity |
| 02/06/2008 | EP1883422A2 Tcr-independent activation of t cells |
| 02/06/2008 | EP1883408A2 Solid compositions and methods for treating middle-of-the night insomnia |
| 02/06/2008 | EP1339712B1 3-substituted quinuclidines and their use as nicotinic agonists |
| 02/06/2008 | EP1324980B1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 02/06/2008 | EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/06/2008 | EP1292619B1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/06/2008 | EP0773939B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/06/2008 | CN101120250A VGP peptide fragments as biomarkers for schizophrenic and bipolar disorders |
| 02/06/2008 | CN101120003A Thieno-pyridine derivatives as GABA-B allosteric enhancers |
| 02/06/2008 | CN101120002A Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 02/06/2008 | CN101119998A Pyrazolo [1,5-a] pyrimidine adenosine a2a receptor antagonists |
| 02/06/2008 | CN101119994A Nicotinic acetycholine receptor ligands |
| 02/06/2008 | CN101119993A Aminophenyl derivatives as selective androgen receptor modulators |
| 02/06/2008 | CN101119992A Tricyclic delta-opioid modulators |
| 02/06/2008 | CN101119989A Chroman derivatives and uses thereof |
| 02/06/2008 | CN101119983A Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 02/06/2008 | CN101119982A Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 02/06/2008 | CN101119981A New benzothiazolesulfonamides |
| 02/06/2008 | CN101119980A New benzothiazolecarboxamides |
| 02/06/2008 | CN101119729A Use of sodium channel blockers and their analogues for the treatment of nicotine dependency |
| 02/06/2008 | CN101119728A Indolomorphinan derivative having carboxy in 6'-position |
| 02/06/2008 | CN101119722A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
| 02/06/2008 | CN101119715A SPM 927 for add-on therapy of schizophrenia |
| 02/06/2008 | CN101119705A Combination of a NMDA receptor antagonist and a MAO-inhibitor or a GADPF-inhibitor for the treatment of central nervous system-related conditions |
| 02/06/2008 | CN101116746A Prevention and treatment of amyloidogenic disease |
| 02/06/2008 | CN101116729A Medicine for helping to give up smoking |
| 02/06/2008 | CN101116728A Oral Chinese traditional medicine for treating |
| 02/06/2008 | CN101116721A Lily relaxing Chinese traditional medicine pills good for sleep |
| 02/06/2008 | CN101116508A Pear brewed with eight treasures |
| 02/06/2008 | CN100366721C Mild wine with aloe as main traditional-Chinese-drug raw material and its production method and use |
| 02/06/2008 | CN100366614C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/06/2008 | CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/06/2008 | CN100366267C Medicine for giving up toxin and its preparation method |
| 02/06/2008 | CN100366254C Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326783 Genetic engineering |
| 02/05/2008 | US7326731 Muscarinic agonists |
| 02/05/2008 | US7326730 Aminoadamantane derivatives as therapeutic agents |
| 02/05/2008 | US7326726 Biaryl substituted triazoles as sodium channel blockers |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
| 02/05/2008 | US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy |
| 02/05/2008 | US7326720 Phenyl- and pyridylpiperidines with TNF activity |
| 02/05/2008 | US7326710 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent |
| 02/05/2008 | US7326709 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326697 Methods for increasing the therapeutic response to electroconvulsive therapy |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 02/05/2008 | US7326682 Conotoxin peptides |
| 02/05/2008 | CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/05/2008 | CA2383315C New derivatives of pyrimidin-4-ones, the process for the preparation thereof and the pharmaceutical compounds that contain them |
| 02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 02/05/2008 | CA2315703C Tripeptidyl peptidase inhibitors |
| 02/05/2008 | CA2264065C Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 01/31/2008 | WO2008014247A2 4 -arylalkoxymethyl-4- phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders |
| 01/31/2008 | WO2008014066A1 Nfkappab inhibitors to treat pain locally |
| 01/31/2008 | WO2008013929A2 Anti-migraine oral spray formulations and methods |
| 01/31/2008 | WO2008013573A1 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory |
| 01/31/2008 | WO2008013270A1 Method for diagnosis of neuropsychiatric disease |
| 01/31/2008 | WO2008013248A1 Process for production of (±)-trans-4-(4- fluorophenyl)-3-hydroxymethylpiperidine |
| 01/31/2008 | WO2008013215A1 Sleep-inducing oral preparation, and oral preparation for amelioration of stress-induced insomnia |
| 01/31/2008 | WO2008013213A1 Prodrug of cinnamide compound |
| 01/31/2008 | WO2008013067A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| 01/31/2008 | WO2008012623A1 Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 01/31/2008 | WO2008012622A2 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 01/31/2008 | WO2008012439A2 Use of a ginkgo biloba extract for the treatment of mitochondrial diseases of genetic origin |
| 01/31/2008 | WO2008012418A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/31/2008 | WO2008012344A1 Naphthalene derivatives used as ep4 receptor agonists |
| 01/31/2008 | WO2008012071A2 Pharmaceutical compositions of nicotine and methods of use thereof |
| 01/31/2008 | WO2008012049A1 Post-translationally modified neurotrophins |
| 01/31/2008 | WO2008012010A1 Fused oxazoles & thiazoles as histamine h3- receptor ligands |
| 01/31/2008 | WO2008011752A2 Drugs for resisting bacteria, viruses, cancers, tumors, irritabilities and defects |
| 01/31/2008 | WO2007135426A3 Treatment of neurodegeneratives diseases |
| 01/31/2008 | WO2007127448A3 Salts of pyridazine compounds |
| 01/31/2008 | WO2007119116A3 Improved synthesis and preparations of duloxetine salts |
| 01/31/2008 | WO2007100282A8 New salts of an indole derivative and their use in medicine |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027140 Combinations of Serotonin Reuptake Inhibitors and Imidazoline I 2 Agonists |
| 01/31/2008 | US20080027135 Methods For Identifying Chemical Modulators Of Ras Superfamily Gptase Activity |
| 01/31/2008 | US20080027128 Duloxetine HCL polymorphs |
| 01/31/2008 | US20080027127 Trans Pyrrolidinyl Derivates and Their Pharmaceutical Use |
| 01/31/2008 | US20080027124 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
| 01/31/2008 | US20080027123 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating erythema nodosum leprosum in leprosy, rhematoid spondylitis, hepatitis or congestive heart failure |
| 01/31/2008 | US20080027121 Novel pyrone-indole derivatives and process for their preparation |
| 01/31/2008 | US20080027120 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 01/31/2008 | US20080027119 Methods and compositions employing bicifadine for the treatment of acute pain, chronic pain, and symptoms of neuropathic disorders |
| 01/31/2008 | US20080027116 Pharmaceutical Composition for Treating Spinocerebellar Ataxia |
| 01/31/2008 | US20080027106 Methods of treating psychosis and schizphrenia based on polymorphisms in the cntf gene |
| 01/31/2008 | US20080027100 Functionally selective alpha2C adrenoreceptor agonists |
| 01/31/2008 | US20080027095 Use Of 3-Substituted-2-(Diphenylmethy)-1-Azabicyclo[2.2.2]Octanes For Treating Mrg-X1 Receptor Mediated Diseases |
| 01/31/2008 | US20080027090 N-5,6,9,10,11,12-hexahydro-4H,8H-cyclohepta[4,5]pyrrolo[3,2,1-ij]quinolin-2-yl-3,3-dimethylbutanamide; for treating cardiovascular disorders, nervous system disorders e.g epilepsy, episodic ataxia type 1, paroxysmal dyskinesia, neurodegenerative spincerebrallar ataxia, Parkinson's disease |
| 01/31/2008 | US20080027089 Formed by reacting rapamycin or an analog with an optionally substituted olefin to fuse the C26NO2 ring with a vinylene group to form a fused cyclohexene ring, which may then be hydrogenated to a cyclohexane ring; neuroprotective agents |